Myocardial deformation and total atrial conduction time in the prediction of cardiac involvement in patients with pulmonary sarcoidosis

Clinical Respiratory Journal

Volumn 11, Issue 1, 2017, Pages 68-77

  Değirmenci, Hüsnü ^a   Demirelli, Selami ^b   Arısoy, Arif ^c   Ermiş, Emrah ^b   Araz, Ömer ^d   Bakırcı, Eftal Murat ^a   Hamur, Hikmet ^a   Büyüklü, Mutlu ^a   Topal, Ergün ^a  

^a ERZINCAN UNIVERSITY   (Turkey)

^b Education and Research Hospital ^*  (Turkey)

^c GAZIOSMANPASA UNIVERSITY   (Turkey)

^d ATATURK UNIVERSITY   (Turkey)

Author keywords

atrial conduction; atrial strain; mortality; pulmonary sarcoidosis

Indexed keywords

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; ELECTROPHYSIOLOGY; FEMALE; HEART ATRIUM CONDUCTION; HEART LEFT VENTRICLE FUNCTION; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; LEFT ATRIAL GLOBAL LONGITUDINAL STRAIN; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYOCARDIAL DISEASE; PREDICTION; PRIORITY JOURNAL; REPRODUCIBILITY; SPECKLE TRACKING ECHOCARDIOGRAPHY; TOTAL ATRIAL CONDUCTION TIME; TWO DIMENSIONAL ECHOCARDIOGRAPHY; ABNORMALITIES; CASE CONTROL STUDY; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; HEART ATRIUM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; SARCOIDOSIS, PULMONARY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84930074670     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/crj.12307     Document Type: Article

References (42)

1. Hunninghake GW, Costabel U, Ando M, Baughman R. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160: 736–755.
2. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation. 1978;58: 1204–1211.
3. Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med. 1977;63: 86–108.
4. Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164: 1885–1889.
5. Mohsen A, Jimenez A, Hood RE, Dickfeld T, Saliaris A, Shorofsky S, Saba MM. Cardiac sarcoidosis: electrophysiological outcomes on long-term follow-up and the role of the implantable cardioverter-defibrillator. J Cardiovasc Electrophysiol. 2014;25: 171–176.
6. Sekhri V, Sanal S, Delorenzo LJ, Aronow WS, Maguire GP. Cardiac sarcoidosis: a comprehensive review. Arch Med Sci. 2011;7: 546–554.
7. Nery PB, Leung E, Birnie DH. Arrhythmias in cardiac sarcoidosis: diagnosis and treatment. Curr Opin Cardiol. 2012;27: 181–189.
8. Biviano AB, Bain W, Whang W, Leitner J, Dizon J, Hickey K, Garan H. Focal left atrial tachycardias not associated with prior catheter ablation for atrial fibrillation: clinical and electrophysiological characteristics. Pacing Clin Electrophysiol. 2012;35: 17–27.
9. Fleming HA. Sarcoidosis of the heart. Am J Med. 1978;64: 915–916.
10. Viles-Gonzalez JF, Pastori L, Fischer A, Wisnivesky JP, Goldman MG, Mehta D. Supraventricular arrhythmias in patients with cardiac sarcoidosis: prevalence, predictors and clinical implications. Chest. 2013;143: 1085–1089.
11. Fleming HA. Cardiac sarcoidosis. Semin Respir Med. 1986;8: 65–71.
12. Marwick TH. Measurement of strain and strain rate by echocardiography: ready for prime time? J Am Coll Cardiol. 2006;47: 1313–1327.
13. Thomas G. Response to ‘non-Doppler two dimensional strain imaging by echocardiography – from technical considerations to clinical applications’. J Am Soc Echocardiogr. 2007;20: 1020–1024.
14. Dandel M, Hetzer R. Echocardiographic strain and strain rate imaging – clinical applications. Int J Cardiol. 2009;132: 11–24.
15. Uusitalo AL, Uusitalo AJ, Rusko HK. Exhaustive endurance training for 6–9 weeks did not induce changes in intrinsic heart rate and cardiac autonomic modulation in female athletes. Int J Sports Med. 1998;19: 532–540.
16. Urheim S, Edvardsen T, Torp H, Angelsen B, Smiseth OA. Myocardial strain by Doppler echocardiography: validation of a new method to quantify regional myocardial function. Circulation. 2000;102: 1158–1164.
17. Kuecherer HF, Kee LL, Modin G, et al. Echocardiography in serial evaluation of left ventricular systolic and diastolic function: importance of image acquisition, quantitation, and physiologic variability in clinical and investigational applications. J Am Soc Echocardiogr. 1991;4: 203–214.
18. Heimdal A, Stoylen A, Torp H, Skjaerpe T. Real time strain rate imaging of the left ventricle by ultrasound. J Am Soc Echocardiogr. 1998;11: 1013–1019.
19. Pavlopoulos H, Nihoyannopoulos P. Strain and strain rate deformation parameters: from tissue Doppler to 2D speckle tracking. Int J Cardiovasc Imaging. 2008;24: 479–491.
20. Yazaki Y, Isobe M, Hiramitsu S, et al. Comparison of clinical features and prognosis of cardiac sarcoidosis and idiopathic dilated cardiomyopathy. Am J Cardiol. 1998;82: 537–540.
21. Rizzato G. Extrapulmonary presentation of sarcoidosis. Curr Opin Pulm Med. 2001;7(5): 295–297.
22. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18: 1440–1463.
23. Merckx KL, De Vos CB, Palmans A, et al. Atrial activation time determined by transthoracic Doppler tissue imaging can be used as an estimate of the total duration of atrial electrical activation. J Am Soc Echocardiogr. 2005;18: 940–944.
24. Vanhaleweyk G, el Ramahi KM, Hazmi M, Sieck JO, Zaman L, Fawzy M. Right atrial, right ventricular and left ventricular thrombi in Behçet's disease. Eur Heart J. 1990;11: 957–959.
25. Weijs B, de Vos CB, Tieleman RG, et al. Clinical and echocardiographic correlates of intra-atrial conduction delay. Europace. 2011;13: 1681–1687.
26. Pytkowski M, Jankowska A, Maciag A, et al. Paroxysmal atrial fibrillation is associated with increased intra-atrial conduction delay. Europace. 2008;10: 1415–1420.
27. Suranagi VV, Malurand PR, Bannur HB. Cardiac sarcoidosis causing sudden death. Indian J Pathol Microbiol. 2009;52(4): 566–567.
28. Uemura A, Morimoto S, Hiramitsu S, et al. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J. 1999;138(2): 299–302.
29. Ramaraj R. Role of the renin-angiotensin system in the promotion of atrial fibrillation. Acta Cardiol. 2009;64(6): 843–844.
30. Lorenz CH, Pastorek JS, Bundy JM. Delineation of normal human left ventricular twist throughout systole by tagged cine magnetic resonance imaging. J Cardiovasc Magn Reson. 2000;2: 97–108.
31. Kurt M, Wang J, Torre-Amione G, Nagueh SF. Left atrial function in diastolic heart failure. Circ Cardiovas İmaging. 2009;2: 10–15.
32. Rademakers FE, Buchalter MB, Rogers WJ, et al. Dissociation between left ventricular untwisting and filling. Circulation. 1992;85: 1572–1581.
33. Notomi Y, Martin-Miklovic MG, Oryszak SJ, et al. Enhanced ventricular untwisting during exercise. Circulation. 2006;113: 2524–2533.
34. Wu Y, Kovács SJ. Frequency-based analysis of the early rapid filling pressure-flow relation elucidates diastolic efficiency mechanisms. Am J Physiol Heart Circ Physiol. 2006;291: 2942–2949.
35. Angomachalelis N, Hourzamanis A, Vamvalis C, Gavrielides A. Doppler echocardiographic evaluation of left ventricular diastolic function in patients with systemic sarcoidosis. Postgrad Med J. 1992;68: S52–56.
36. Skold CM, Larsen FF, Rasmussen E, Pehrsson SK, Eklund AG. Determination of cardiac involvement in sarcoidosis by magnetic resonance imaging and Doppler echocardiography. J Intern Med. 2002;252: 465–471.
37. Fahy GJ, Marwick T, McCeery CJ, Quigley PJ, Maurer BJ. Doppler echocardiographic detection of left ventricular diastolic dysfunction in patients with pulmonary sarcoidosis. Chest. 1996;109: 62–66.
38. Silverman KJ, Huchins GM, Bulkley BH. Cardiac sarcoid. Circulation. 1978;58: 1204–1211.
39. Matsui Y, Iwai K, Tachibana T, et al. Clinicopathological study on fatal myocardial sarcoidosis. Ann NY Acad Sci. 1976;278: 455–469.
40. Lemery R, McGoon MD, Edwards WD. Cardiac sarcoidosis potentially treatable form of myocarditis. Mayo Clin Proc. 1985;60: 549–554.
41. Yazaki Y, Isobe M, Hiroe M, et al. Central Japan Heart Study Group: prognostic determinants of long term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol. 2001;88: 1006–1010.
42. Pierre-Louis B, Prasad A, Frishman WH. Cardiac manifestations of sarcoidosis and therapeutic options. Cardiol Rev. 2009;17: 153–158.